Business

Announcement on Deferring the Reply to the "Inquiry Letter Regarding the Review of Beijing Sun-Novo Pharmaceutical Research Co.,Ltd.’s Share Issuance and Convertible Bond Issuance for Asset Acquisition and Raising of Supporting Funds, and Related Party Transaction"

Announcement on Deferring the Reply to the "Inquiry Letter Regarding the Review of Beijing Sun-Novo Pharmaceutical Research Co.,Ltd.’s Share Issuance and Convertible Bond Issuance for Asset Acquisition and Raising of Supporting Funds, and Related Party Transaction"

articleBeijing Sun-novo Pharmaceutical Research Co. Ltd. Class ADecember 26, 20253/news/announcement-on-deferring-the-reply-to-the-inquiry-letter-regarding-the-review-of-beijing-sun-novo-pharmaceutical-research-coltds-share-issuance-and-convertible-bond-issuance-for-asset-acquisition-and-raising-of-supporting-funds-and-related-party-transaction
Announcement on Deferring the Reply to the "Inquiry Letter Regarding the Review of Beijing Sun-Novo Pharmaceutical Research Co.,Ltd.’s Share Issuance and Convertible Bond Issuance for Asset Acquisition and Raising of Supporting Funds, and Related Party Transaction"

About this update from Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A

Announcement on Deferring the Reply to the "Inquiry Letter Regarding the Review of Beijing Sun-Novo Pharmaceutical Research Co.,Ltd.’s Share Issuance and Convertible Bond Issuance for Asset Acquisition and Raising of Supporting Funds, and Related Party Transaction" The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A